XML 60 R29.htm IDEA: XBRL DOCUMENT v3.23.1

COMMITMENTS AND CONTINGENCIES (Detail Textuals) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Patent Transfer Agreement [Member]
Commitments [Line Items]
Percentage of net revenues	3.00%
D.N.A Biomedical Solutions Ltd [Member] | Joint Venture Agreement [Member]
Commitments [Line Items]
Amount of investment in entity	$ 600
D. N. A Biomedical Solutions Ltd And Oramed Ltd [Member] | Joint Venture Agreement [Member]
Commitments [Line Items]
Percentage of ownership of entity acquired	50.00%
Government of Israel [Member]
Commitments [Line Items]
Percentage sales of products developed from projects in first three years, from commencement of revenues	3.00%
Percentage sales of products developed from projects subsequent three years	4.00%
Percentage sales of products developed from projects commencing the seventh year up to 100% of amount of grant received	5.00%
Total royalty amount payable	$ 460
Percentage of each payment received from Amgen	5.38%
Royalty amount paid	$ 83

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	entx_CommitmentsLineItems
Namespace Prefix:	entx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the amount paid for royalty to IIA.

+ References

No definition available.

+ Details

Name:	entx_PaymentOfRoyaltyGuaranteesCommitments
Namespace Prefix:	entx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Represents the percentage of each payment received from Amgen.

+ References

No definition available.

+ Details

Name:	entx_RoyaltyGuaranteesCommitmentsPercentageOfEachPaymentReceivedFromAmgen
Namespace Prefix:	entx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the percentage of net revenues.

+ References

No definition available.

+ Details

Name:	entx_RoyaltyGuaranteesCommitmentsPercentageOfNetRevenues
Namespace Prefix:	entx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the percentage sales of products developed from projects commencing the seventh year.

+ References

No definition available.

+ Details

Name:	entx_RoyaltyGuaranteesCommitmentsPercentageSalesOfProductsDevelopedFromProjectsCommencingSeventhYear
Namespace Prefix:	entx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the percentage sales of products developed from projects in first three years, from commencement of revenues.

+ References

No definition available.

+ Details

Name:	entx_RoyaltyGuaranteesCommitmentsPercentageSalesOfProductsDevelopedFromProjectsInFirstThreeYearsFromCommencementOfRevenues
Namespace Prefix:	entx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the percentage sales of products developed from projects subsequent three years.

+ References

No definition available.

+ Details

Name:	entx_RoyaltyGuaranteesCommitmentsPercentageSalesOfProductsDevelopedFromProjectsSubsequentThreeYears
Namespace Prefix:	entx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the amount invested in the entity.

+ References

No definition available.

+ Details

Name:	entx_SaleOfStockAmountOfInvestment
Namespace Prefix:	entx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Represents the percentage of ownership of entity acquired.

+ References

No definition available.

+ Details

Name:	entx_SaleOfStockPercentageOfOwnershipOfEntityAcquired
Namespace Prefix:	entx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount the entity has committed to make for future royalty guarantees.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 928
-SubTopic 440
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013

+ Details

Name:	us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Details

Name:	entx_AgreementAxis=entx_PatentTransferAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=entx_DnaBiomedicalSolutionsLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	entx_AgreementAxis=entx_JointVentureAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=entx_DnaBiomedicalSolutionsLtdAndOramedLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AccountsNotesLoansAndFinancingReceivablesByLegalEntityOfCounterpartyTypeAxis=us-gaap_GovernmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: